Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regina Alemany

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Investigation|August 20, 2015
RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomasAntònia Obrador-Hevia, Esther Martinez-Font, Irene Felipe-Abrio, et al.
Molecular Pharmacology|November 9, 2004
Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minervalJordi Martínez, Oliver Vögler, Jesús Casas, et al.
Molecular Pharmacology|March 21, 2008
Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cellsJordi M Serra, Antonio Gutiérrez, Regina Alemany, et al.
Frontiers in Immunology|November 29, 2023
Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experienceAntonio Gutierrez, Aser Alonso, Marta Garcia-Recio, et al.
European Journal of Pharmacology|March 5, 2011
Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of actionJordi Martínez-Serra, Elena Maffiotte, Javier Martín, et al.
Cancers|February 25, 2022
Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell LymphomaLeyre Bento, Oliver Vögler, Adriana Sas-Barbeito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Cancers|October 17, 2020
Prognostic Impact of <i>let-7e</i> MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma StudyJavier Martin-Broto, Antonio López Pousa, Ramón de Las Peñas, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Investigation|August 20, 2015
RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomasAntònia Obrador-Hevia, Esther Martinez-Font, Irene Felipe-Abrio, et al.
Molecular Pharmacology|November 9, 2004
Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minervalJordi Martínez, Oliver Vögler, Jesús Casas, et al.
Molecular Pharmacology|March 21, 2008
Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cellsJordi M Serra, Antonio Gutiérrez, Regina Alemany, et al.
Frontiers in Immunology|November 29, 2023
Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experienceAntonio Gutierrez, Aser Alonso, Marta Garcia-Recio, et al.
European Journal of Pharmacology|March 5, 2011
Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of actionJordi Martínez-Serra, Elena Maffiotte, Javier Martín, et al.
Cancers|February 25, 2022
Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell LymphomaLeyre Bento, Oliver Vögler, Adriana Sas-Barbeito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Cancers|October 17, 2020
Prognostic Impact of <i>let-7e</i> MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma StudyJavier Martin-Broto, Antonio López Pousa, Ramón de Las Peñas, et al.
Pageof 3